Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
Cell-based Therapy for Chronic Obstructive Pulmonary Disease. Rebuilding the Lung
1University of Vermont, Burlington, Vermont.
Lung regenerative medicine, including stem cell therapies and bioengineering, offers promising new treatments for lung diseases. These advances are crucial for developing novel therapeutic strategies to combat increasing global prevalence.
Area of Science:
- Regenerative Medicine
- Pulmonary Medicine
- Biotechnology
Background:
- Increasing global prevalence and impact of lung diseases necessitate novel therapeutic strategies.
- Lung regenerative medicine integrates stem cells, cell-based therapies, and bioengineering.
- Existing approaches provide new insights into lung physiology and pathophysiology.
Purpose of the Study:
- To review recent advances in lung regenerative medicine.
- To discuss the applicability of cell-based and bioengineering approaches for lung diseases.
- To highlight mesenchymal stromal cell-based therapies for chronic obstructive pulmonary disease.
Main Methods:
- Review of current literature on lung regenerative medicine.
- Analysis of cell-based therapeutic strategies, focusing on mesenchymal stromal cells.
- Evaluation of bioengineering techniques for lung disease treatment.
Main Results:
- Lung regenerative medicine offers a platform for developing novel therapeutic approaches.
- Mesenchymal stromal cell-based therapies show potential for treating lung diseases.
- Bioengineering approaches are advancing the study and treatment of pulmonary conditions.
Conclusions:
- Advances in regenerative medicine are vital for addressing the growing burden of lung diseases.
- Cell-based and bioengineering strategies represent promising avenues for future lung disease therapies.
- Further research into these areas could lead to significant clinical breakthroughs.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

